010519 Apple M

Trump’s tariff reprieve for consumer electronics: What it means for tech investors

Key points:

  • Consumer electronics get a breather — for now: Trump has paused steep tariffs on consumer electronics, signaling a shift to more strategic, sector-specific protectionism.
  • Semiconductors remain in the spotlight: While exemptions offer temporary relief, Section 232-based tariffs could soon target chips and equipment more directly.
  • The winners are agile and diversified: Investors should focus on firms with resilient supply chains, U.S. manufacturing exposure, and structural tailwinds like AI infrastructure.


From ‘reciprocal’ to ‘sectoral’ tariffs

Trump’s tariff policy just took a sharp turn — again. In what some are calling a strategic reprieve, the White House has excluded major electronics categories from the steepest round of tariffs, which originally imposed a 145% levy on Chinese goods and 10% on imports from other countries.

This move signals a shift from country-specific reciprocal tariff strategy to sector-focused protectionism. While the 20% China tariff remains in place — especially targeting fentanyl-related imports — the U.S. appears to be laying the groundwork for new semiconductor-focused tariffs under Section 232, a national security clause that could make these duties more durable and harder to reverse.

Who wins (for now)?

  • Smartphone makers: Apple avoids the harshest blow, although China-made iPhones still face 20% tariffs. Samsung may also benefit as it could get excluded from the 10% global baseline tariff on South Korea.
  • Chip stocks: Nvidia, Broadcom, Super Micro, Intel, TSMC could gain from exemptions on semiconductor equipment.
  • Big Tech and other Mag 7: Microsoft, Tesla, Amazon, Alphabet, and Meta remain in focus given their exposure to digital infrastructure and hardware.
  • PC makers & server players: Dell and Hewlett Packard Enterprise (HPE) benefit from lower tariffs on servers and components.
  • Suppliers to US fabs: ASML (Netherlands) and Tokyo Electron (Japan) could benefit indirectly from ongoing investment in U.S.-based semiconductor manufacturing.

However, the reprieve may be short-lived, and tech stocks could remain in the crosshairs. Semiconductors are no longer just another component — they’re the lifeblood of modern economies. From AI to EVs and cloud computing, chips power everything.

The administration’s delay in announcing tariffs on semiconductors might reflect awareness of their systemic importance — or, as some suspect, a strategic pause amid bond market volatility and potential market backlash.

Who loses (or still at risk)?

  • Apparel & footwear: No relief in sight. These sectors continue to face tariffs of up to 145% on Chinese goods.
  • Pharma: It has been announced that special sectoral tariffs on drug companies could follow — a risk for global drug supply chains.


What should investors watch?

  • Policy volatility: The U.S. Commerce Secretary has already called this reprieve temporary. That means markets could be whipsawed again if Trump reintroduces electronics duties or implements new semiconductor-specific tariffs.
  • Capex planning uncertainty: With U.S. policies swinging between unilateral tariffs and sectoral exemptions, companies may delay investment decisions. That favors diversified, agile players over those tightly tied to China.
  • Themes to consider:
    • Reshoring and U.S. manufacturing: The CHIPS Act plays into this, alongside tariffs. Domestic manufacturers and U.S. suppliers are likely to remain on the front foot.
    • “Tariff-proof” supply chains: Companies with significant non-China exposure — including Vietnam, Mexico, and India — could be less vulnerable.
    • AI infrastructure buildout: The exemption on servers and PC hardware could support continued investment in AI data centers, benefiting select semiconductor and hardware plays.
 

Investment implications: Prepare for the long game

1. Watch for repricing in chip stocks

A new round of tariffs on semiconductors could weigh on companies heavily exposed to China or reliant on complex global supply chains. Investors may want to:

  • Reassess positions in firms with China-centric revenue or supply exposure.
  • Look at domestic chipmakers or those with diversified production footprints.
 

2. Favor supply chain winners and “tariff-proof” names

Companies with resilient, domestic-oriented supply chains or those with unique IP may weather this storm better than others. Think:

  • Asset-light or IP-driven chip firms like ARM or Nvidia
  • Foundries and equipment makers less dependent on exports

3. Build exposure to re-shoring and “silicon sovereignty”

With semiconductors labeled as critical infrastructure, expect continued momentum behind reshoring and “silicon sovereignty” themes:

  • U.S. Chips Act beneficiaries. Companies like TSMC, Samsung and Intel are building new US factories with support from the 2022 Chips and Science Act.
  • European firms aligned with the EU’s strategic autonomy agenda.
  • Taiwan and Japan players expanding globally and forming supply chain partnerships.


Bottom line: Don’t mistake relief for stability

Trump’s tariff policy continues to be a moving target. While the latest reprieve delivers a short-term win for electronics and AI-related players, the broader trend toward protectionist industrial policy remains firmly intact.

For investors, the message is clear:

  • Prioritize agility, resilience, and policy awareness.
  • Focus on companies with strategic positioning in AI, semiconductor sovereignty, and non-China supply chains.
  • And above all, prepare for volatility as the new normal in global tech investing.

Disclaimer

Confidentiality and Usage:
You may not reproduce, distribute, or transmit this material or any portion thereof without prior written permission from Saxo.

Nature of Information:
The information provided herein is based on current market conditions and analysts' opinions, which may reflect personal views of the author, and are subject to change without notice. This material does not include a record of any trading prices, or an offer of, or solicitation for, or endorsement to enter into any transaction in any investment product. Any forecast on the economy, markets and economic trends of the markets provided is not necessarily indicative of the future or likely performance of the investment product subject of this material.

Responsibility and Liability:
Saxo accepts no liability for any use that may be made of these comments or for any consequences that arise from such use. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

The information provided in this material is solely for information only. It is intended for general circulation and does not take into account the specific investment objectives, financial situation or particular needs of any particular person. Accordingly, it should not be relied on or treated as a substitute for specific advice concerning specific situations of any person. Please seek advice from a financial adviser regarding the suitability of any investment product taking into account your specific investment objectives, financial situation or particular needs before you make a commitment to purchase an investment product. In the event that you choose not to seek advice from a financial adviser, you should consider whether any investment product mentioned in this publication is suitable for you.

Notwithstanding the above, insofar as any information provided herein contains research analyses or reports concerning any investment product authored by any foreign research house and is issued or promulgated to a person in Singapore who is not an accredited investor, expert investor, and/or institutional investor, Saxo Capital Market Pte. Ltd. accepts legal responsibility for the contents of this material to the extent required by law. Recipients of such material are to contact Saxo Capital Markets Pte. Ltd. in respect of any matters arising from, or in connection with, this material.

Risk Disclosure:
Trading in investment products involve significant risk, including the risk of losing your entire investment. Historical returns are not a guarantee of future returns. Prices can both rise and fall, and there is a risk that you will not get back the money you invested.

Conflicts of interest:
The author may hold positions in the investment products mentioned. The author does not own positions in the underlying investment product exceeding 0.5% of its market capitalisation, save as otherwise declared. The author is not permitted to trade the mentioned investment products within the first 24 hours after the publication of this article.

Saxo maintains partnerships with companies that compensate Saxo for promotional activities conducted on its platform. Additionally, Saxo has agreements with certain partners who provide retrocession contingent upon clients purchasing specific investment products offered by these partners. While Saxo receives compensation from these partnerships, all content is conducted with the intention of providing clients with valuable options and information.

Publication details:
If any listed companies are the subject of the material, the content has not been submitted to the companies in question prior to publication.

Please refer to our full disclaimer and notification on non-independent investment research for more details.

Saxo Markets
88 Market Street
CapitaSpring #31-01
Singapore 048948

Contact Saxo

Singapore
Singapore

Saxo Capital Markets Pte Ltd ('Saxo Markets') is a company authorised and regulated by the Monetary Authority of Singapore (MAS) [Co. Reg. No.: 200601141M ] and is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms & Risk Warning to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Saxo is part of the J. Safra Sarasin Group.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Trading in leveraged products such as Margin FX products may result in your losses exceeding your initial deposits. Saxo Markets does not provide financial advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Markets does not take into account an individual’s needs, objectives or financial situation.

The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit www.home.saxo/en-sg/about-us/awards.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website are not intended for residents of the United States, Malaysia and Japan. Please click here to view our full disclaimer.

This advertisement has not been reviewed by the Monetary Authority of Singapore.

Apple and the Apple logo are trademarks of Apple Inc, registered in the US and other countries and regions. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.